Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: A prospective study
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 97 (4) , 827-836
- https://doi.org/10.1016/0016-5085(89)91485-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Famotidine in the therapy of gastric hypersecretory statesThe American Journal of Medicine, 1986
- Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonistsDigestive Diseases and Sciences, 1986
- Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonistsGastroenterology, 1985
- Omeprazole: Effective, Convenient Therapy for Zollinger—Ellison SyndromeGastroenterology, 1985
- Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.Gut, 1984
- Omeprazole in Zollinger–Ellison SyndromeNew England Journal of Medicine, 1984
- Comparison of Ranitidine and Cimetidine in the Treatment of Gastric HypersecretionAnnals of Internal Medicine, 1984
- Effect of isopropamide on response to oral cimetidine in patients with Zollinger-Ellison syndromeDigestive Diseases and Sciences, 1982
- Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPaseNature, 1981
- H2-Histamine Receptor Blocking Agents in the Zollinger-Ellison SyndromeAnnals of Internal Medicine, 1977